Brian Markison
2020
In 2020, Brian Markison earned a total compensation of $3.8M as President and Chief Executive Officer at RVL Pharmaceuticals plc, a 12% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $690,000 |
|---|---|
| Salary | $715,923 |
| Stock Awards | $2,427,930 |
| Total | $3,833,853 |
Markison received $2.4M in stock awards, accounting for 63% of the total pay in 2020.
Markison also received $690K in non-equity incentive plan and $715.9K in salary.
Rankings
In 2020, Brian Markison's compensation ranked 2,985th out of 13,090 executives tracked by ExecPay. In other words, Markison earned more than 77.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,985 out of 13,090 | 77th |
Division Manufacturing | 1,160 out of 5,624 | 79th |
Major group Chemicals And Allied Products | 436 out of 2,257 | 81st |
Industry group Drugs | 378 out of 1,957 | 81st |
Industry Pharmaceutical Preparations | 279 out of 1,462 | 81st |
Source: SEC filing on April 26, 2021.
Markison's colleagues
We found three more compensation records of executives who worked with Brian Markison at RVL Pharmaceuticals plc in 2020.
News
RVL Pharmaceuticals plc Former EVP, Research & Development Tina deVries' 2022 pay slips 19% to $561K
April 24, 2023
RVL Pharmaceuticals plc CEO Brian Markison's 2021 pay falls 63% to $1.4M
April 25, 2022
RVL Pharmaceuticals plc CEO Brian Markison's 2020 pay slips 12% to $3.8M
April 26, 2021
RVL Pharmaceuticals plc CEO Brian Markison's 2019 pay jumps 291% to $4.3M
April 20, 2020
RVL Pharmaceuticals plc CEO Brian Markison's 2018 pay slips 10% to $1.1M
April 26, 2019